Pulmonx (LUNG) EPS (Diluted) Growth (1y) (2021 - 2025)
Pulmonx (LUNG) EPS (Diluted) Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 13.96% |
| 10 | Pulmonx | 93.95 Mn | 24.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.38% |
| Jun 30, 2025 | 4.59% |
| Mar 31, 2025 | -1.51% |
| Dec 31, 2024 | 8.16% |
| Sep 30, 2024 | 8.07% |
| Jun 30, 2024 | 8.00% |
| Mar 31, 2024 | 15.61% |
| Dec 31, 2023 | 5.01% |
| Sep 30, 2023 | -2.86% |
| Jun 30, 2023 | -8.24% |
| Mar 31, 2023 | 2.05% |
| Dec 31, 2022 | -7.03% |
| Sep 30, 2022 | -36.43% |
| Jun 30, 2022 | -9.84% |
| Mar 31, 2022 | -21.50% |
| Dec 31, 2021 | 60.56% |
| Sep 30, 2021 | 79.63% |
| Jun 30, 2021 | 94.17% |